GENESCO INC (GCO)

US3715321028 - Common Stock

26.51  -0.26 (-0.97%)

Fundamental Rating

4

Overall GCO gets a fundamental rating of 4 out of 10. We evaluated GCO against 126 industry peers in the Specialty Retail industry. GCO has an average financial health and profitability rating. GCO has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

GCO had positive earnings in the past year.
GCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: GCO reported negative net income in multiple years.
GCO had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

GCO has a Return On Assets (-1.27%) which is in line with its industry peers.
GCO has a Return On Equity (-2.95%) which is in line with its industry peers.
GCO has a Return On Invested Capital of 1.24%. This is comparable to the rest of the industry: GCO outperforms 44.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GCO is significantly below the industry average of 13.85%.
The 3 year average ROIC (6.45%) for GCO is well above the current ROIC(1.24%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.27%
ROE -2.95%
ROIC 1.24%
ROA(3y)3.68%
ROA(5y)2.23%
ROE(3y)9.32%
ROE(5y)5.59%
ROIC(3y)6.45%
ROIC(5y)N/A

1.3 Margins

The Operating Margin of GCO (0.67%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of GCO has declined.
GCO has a Gross Margin of 47.27%. This is in the better half of the industry: GCO outperforms 73.81% of its industry peers.
GCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.67%
PM (TTM) N/A
GM 47.27%
OM growth 3YN/A
OM growth 5Y-29.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.63%
GM growth 5Y-0.24%

5

2. Health

2.1 Basic Checks

GCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GCO has less shares outstanding than it did 1 year ago.
GCO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for GCO has been reduced compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of GCO is 1.01, which is an excellent value as it means it would take GCO, only 1.01 years of fcf income to pay off all of its debts.
GCO has a better Debt to FCF ratio (1.01) than 78.57% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that GCO is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.06, GCO is doing good in the industry, outperforming 73.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 1.01
Altman-Z N/A
ROIC/WACC0.12
WACC10.2%

2.3 Liquidity

A Current Ratio of 1.59 indicates that GCO should not have too much problems paying its short term obligations.
The Current ratio of GCO (1.59) is comparable to the rest of the industry.
A Quick Ratio of 0.40 indicates that GCO may have some problems paying its short term obligations.
GCO has a worse Quick ratio (0.40) than 65.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 0.4

4

3. Growth

3.1 Past

GCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.46%.
The earnings per share for GCO have been decreasing by -25.37% on average. This is quite bad
GCO shows a decrease in Revenue. In the last year, the revenue decreased by -2.53%.
The Revenue has been growing slightly by 1.21% on average over the past years.
EPS 1Y (TTM)-87.46%
EPS 3YN/A
EPS 5Y-25.37%
EPS growth Q2Q-15.36%
Revenue 1Y (TTM)-2.53%
Revenue growth 3Y9.17%
Revenue growth 5Y1.21%
Revenue growth Q2Q1.92%

3.2 Future

The Earnings Per Share is expected to grow by 34.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.39% on average over the next years.
EPS Next Y-8.82%
EPS Next 2Y74.07%
EPS Next 3Y34.9%
EPS Next 5YN/A
Revenue Next Year-2.51%
Revenue Next 2Y-0.72%
Revenue Next 3Y1.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

GCO is valuated quite expensively with a Price/Earnings ratio of 36.82.
GCO's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 25.20. GCO is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 40.38, GCO can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as GCO.
When comparing the Price/Forward Earnings ratio of GCO to the average of the S&P500 Index (21.60), we can say GCO is valued expensively.
Industry RankSector Rank
PE 36.82
Fwd PE 40.38

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GCO is valued cheaper than 89.68% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GCO indicates a rather cheap valuation: GCO is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.82
EV/EBITDA 4.71

4.3 Compensation for Growth

GCO's earnings are expected to grow with 34.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.07%
EPS Next 3Y34.9%

0

5. Dividend

5.1 Amount

GCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENESCO INC

NYSE:GCO (4/24/2024, 8:51:55 AM)

26.51

-0.26 (-0.97%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap304.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 36.82
Fwd PE 40.38
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.27%
ROE -2.95%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.67%
PM (TTM) N/A
GM 47.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.59
Quick Ratio 0.4
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-87.46%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-8.82%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.53%
Revenue growth 3Y9.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y